These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36636586)

  • 1. Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases.
    Koenig MK; Russo SN; McBride KL; Bjornsson HT; Gunnarsdottir BB; Goldstein A; Falk SA
    JIMD Rep; 2023 Jan; 64(1):65-70. PubMed ID: 36636586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.
    Sabbah HN
    Heart Fail Rev; 2022 Sep; 27(5):1911-1923. PubMed ID: 34623544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism.
    Reid Thompson W; Hornby B; Manuel R; Bradley E; Laux J; Carr J; Vernon HJ
    Genet Med; 2021 Mar; 23(3):471-478. PubMed ID: 33077895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.
    Karaa A; Haas R; Goldstein A; Vockley J; Weaver WD; Cohen BH
    Neurology; 2018 Apr; 90(14):e1212-e1221. PubMed ID: 29500292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome.
    Hornby B; Thompson WR; Almuqbil M; Manuel R; Abbruscato A; Carr J; Vernon HJ
    Orphanet J Rare Dis; 2022 Sep; 17(1):336. PubMed ID: 36056411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data.
    Van den Eynde J; Chinni B; Vernon H; Thompson WR; Hornby B; Kutty S; Manlhiot C
    Orphanet J Rare Dis; 2023 Apr; 18(1):76. PubMed ID: 37041653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
    Petcherski A; Trudeau KM; Wolf DM; Segawa M; Lee J; Taddeo EP; Deeney JT; Liesa M
    J Mol Biol; 2018 Dec; 430(24):4823-4833. PubMed ID: 30389435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies.
    Wasmus C; Dudek J
    Life (Basel); 2020 Nov; 10(11):. PubMed ID: 33187128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
    Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
    Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and natural history of Barth Syndrome: An overview.
    Taylor C; Rao ES; Pierre G; Chronopoulou E; Hornby B; Heyman A; Vernon HJ
    J Inherit Metab Dis; 2022 Jan; 45(1):7-16. PubMed ID: 34355402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting mitochondrial dysfunction with elamipretide.
    Obi C; Smith AT; Hughes GJ; Adeboye AA
    Heart Fail Rev; 2022 Sep; 27(5):1925-1932. PubMed ID: 35037146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future treatment approaches for Barth syndrome.
    Thompson R; Jefferies J; Wang S; Pu WT; Takemoto C; Hornby B; Heyman A; Chin MT; Vernon HJ
    J Inherit Metab Dis; 2022 Jan; 45(1):17-28. PubMed ID: 34713454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies.
    Bertero E; Kutschka I; Maack C; Dudek J
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165803. PubMed ID: 32348916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
    Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
    Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome.
    Gebert N; Joshi AS; Kutik S; Becker T; McKenzie M; Guan XL; Mooga VP; Stroud DA; Kulkarni G; Wenk MR; Rehling P; Meisinger C; Ryan MT; Wiedemann N; Greenberg ML; Pfanner N
    Curr Biol; 2009 Dec; 19(24):2133-9. PubMed ID: 19962311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Barth Syndrome by Cardiolipin Manipulation (CARDIOMAN) With Bezafibrate: Protocol for a Randomized Placebo-Controlled Pilot Trial Conducted in the Nationally Commissioned Barth Syndrome Service.
    Dabner L; Pieles GE; Steward CG; Hamilton-Shield JP; Ness AR; Rogers CA; Bucciarelli-Ducci C; Greenwood R; Ellis L; Sheehan K; Reeves BC
    JMIR Res Protoc; 2021 May; 10(5):e22533. PubMed ID: 34057417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations.
    Daneshgar N; Liang PI; Lan RS; Horstmann MM; Pack L; Bhardwaj G; Penniman CM; O'Neill BT; Dai DF
    Kidney Int; 2022 May; 101(5):906-911. PubMed ID: 34953771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome.
    Gaspard GJ; McMaster CR
    Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes.
    Lu YW; Claypool SM
    Front Genet; 2015; 6():3. PubMed ID: 25691889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.